MDGL Sale Disclosure
Sibold William John · SEC Form 4 · Filed Sep 11, 2026
Sale
Calculated transaction value
$56.61K
Sibold William John President And CEO
MDGL
Transaction date
Sep 11, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed same day
MDGL daily price context
Close on/before transaction
$534.49
Sep 11, 2026
Close before public filing
$533.12
Sep 10, 2026
Return since public filing
+0.26%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 106 shares @ $534.06
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-061581
Filing cohort
Transactions in this filing
Showing 15 of 24
Trades
24
Issuers
1
Estimated value
$6.24M
Buys / sales
0 / 24
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $31.99K |
| Madrigal Pharmaceuticals, Inc. MDGL Current | Sale | Sep 11, 2026 | $56.61K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $116.84K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $86.02K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $371.38K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $199.32K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $652.21K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $837.25K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $414.62K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $65.57K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 9, 2026 | $115.89K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 9, 2026 | $272.8K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 9, 2026 | $69.15K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 9, 2026 | $86.81K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 9, 2026 | $196.08K |